| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c29ebbacb306f9b12e38ffad61728746 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1996-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352f979b45ba21a89cc15ddfe1454acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_453a3a184e47237b086d1fcbd4258d43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb6387c98592cdf6966e1cebde8b9e5 |
| publicationDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-292134-B6 |
| titleOfInvention |
A pharmaceutical composition for the treatment of a patient suffering from asthma and the use of ultra-low molecular weight heparins |
| abstract |
Pharmaceutical Formulation for Patient Suffering from Antigen-Induced Asthma Containing at least 0.05 mg and 1.0 milligram of Heparin with Ultrason Molecular Weight per kilogram Weight of Patient in Pharmaceutically Acceptable the vehicle, the ultrasound molecular weight heparins having an average molecular weight of 3000 or less are disclosed. Use heparin for ultra high molecular weight molecules, their average molecular weight is 3,000 or less for the production of pharmaceuticals containing 0.05 and 1.0 milligrams of heparin with ultra high molecular weight per kilogram of body weight. weight of the patient in each of the pharmaceutically acceptable vehicles for antigen-induced asthma. \ t |
| priorityDate |
1995-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |